Numerous studies suggest that inactivation of one or more tumor suppressor genes may represent early and/or necessary steps in the neoplastic transformation of liver. Human chromosome 11 has been implicated in the pathogenesis of several human tumors, including hepatoblastoma and hepatocellular carcinoma, and is syntenic to rat chromosome 1, which is structurally altered in many rat liver tumor cell lines, suggesting that these chromosomes may contain a common liver tumor suppressor gene. We have suggested that chromosome tranfer studies utilizing human chromsomes and rat liver tumor cell lines may facilitate the facile localization, identification, and cloning of human genes responsible for tumor suppression in liver. To this end, we have employed a microcell hybrid model to demonstrate the existence of a liver tumor suppressor on human chromosome 11, map its location to 11p11.2, and identify candidate ESTs/genes. The continuing long-term goal of this research project is to determine the role of the human 11p11.2 liver tumor suppressor gene in the molecular pathogenesis of hepatocellular carcinoma, and to determine the mechanisms that govern the loss of function of this tumor suppressor in multi-step hepatocarcinogenesis in humans. The proposed investigations focus on a small group of candidate liver tumor suppressor genes that were identified during the initial funding period, and extend/advance our ongoing studies aimed at characterizing these candidate genes. The goals of this proposal are to (i) characterize the involvement of candidate liver tumor suppressor genes in the suppression of the neoplastic phenotype of rat liver tumor cell lines using siRNA in vitro and in vivo, (ii) determine the ability of candidate genes to express tumor suppressor activity in vivo using transfected cell lines, (iii) evaluate the possible contributions of epigenetic mechanisms to the regulation of candidate liver tumor suppressor gene expression, (iv) examine the role of genetic alterations (LOH and/or mutation) in the inactivation of candidate liver tumor suppressor gene expression, (v) determine if alterations in candidate liver tumor suppressor gene expression represent early or later molecular alterations in multi-step hepatocarcinogenesis, and (vi) identify molecular targets and pathways in liver tumor cell lines that are subject to direct or indirect modification in response to candidate gene expression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA078434-06A1
Application #
6720877
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Okano, Paul
Project Start
1998-07-01
Project End
2008-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
6
Fiscal Year
2003
Total Cost
$255,500
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pathology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Jahn, Jennifer E; Best, D Hunter; Coleman, William B (2010) Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition. Exp Mol Pathol 89:209-16
Jahn, Jennifer E; Coleman, William B (2008) Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line. Int J Oncol 32:441-9
Rivenbark, Ashley G; Livasy, Chad A; Boyd, Courtney E et al. (2007) Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. Exp Mol Pathol 83:188-97
Best, D Hunter; Coleman, William B (2007) Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. J Hepatol 46:1055-63
Best, D Hunter; Butz, Genelle M; Moller, Karen et al. (2004) Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors. Int J Oncol 25:17-25
Rider, Michelle A; Butz, Genelle M; Ricketts, Sharon L et al. (2002) Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2. Int J Oncol 20:235-45
Gordon, Gavin J; Butz, Genelle M; Grisham, Joe W et al. (2002) Isolation, short-term culture, and transplantation of small hepatocyte-like progenitor cells from retrorsine-exposed rats. Transplantation 73:1236-43
Ricketts, Sharon L; Garcia, Nicole F; Betz, Bryan L et al. (2002) Identification of candidate liver tumor suppressor genes from human 11p11.2-p12. Genes Chromosomes Cancer 33:47-59
Gordon, G J; Coleman, W B; Hixson, D C et al. (2000) Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol 156:607-19
Gordon, G J; Coleman, W B; Grisham, J W (2000) Bax-mediated apoptosis in the livers of rats after partial hepatectomy in the retrorsine model of hepatocellular injury. Hepatology 32:312-20

Showing the most recent 10 out of 14 publications